National database tracking robotic prostate cancer surgery outcomes in Australia
Collects long-term records of robotic prostate removal surgery and patient questionnaires in men.
Plain-language title generated from the registry record
Registry title: National Robotics-Assisted Radical Prostatectomy Database
Key facts
- Where
- Ballarat, Geelong, and Melbourne, AustraliaSee the 8 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06279260, who can take part
Where in Australia
- Ballarat HealthBallarat, AustraliaNot yet recruiting
- Barwon HealthGeelong, AustraliaNot yet recruiting
- Austin HealthcareMelbourne, AustraliaNot yet recruiting
- E.J Whitten Prostate Cancer Centre, Epworth HealthcareMelbourne, AustraliaNot yet recruiting
- Peter MacCallum Cancer CentreMelbourne, AustraliaNot yet recruiting
- Royal Melbourne HospitalMelbourne, AustraliaTaking people
- St. Vincent's Private HospitalMelbourne, AustraliaNot yet recruiting
- Western HeathMelbourne, AustraliaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Melbourne Health
- Trial code
- NCT06279260
- Record updated
- 26 August 2024
- Original description
In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients.Read full original descriptionShow less
National Robotics-Assisted Radical Prostatectomy Database: Exploring Learning Curves and Long Term Surgical, Oncological and Patient Reported Outcome Measures (PROMS)
In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients.
Studies conducted so far are small scale studies and the results from these studies cannot be generalized to the population at large in Australia. So, there is need for a largescale study that will look at the long-term outcomes and the factors that impact robotic surgeries across the metropolitan and rural hospital sectors.
Hence, this comprehensive database has been setup to collaborate with major hospitals, across metropolitan and rural areas in Australia. Through this database, researchers will be able to explore the diagnostic pathway for Prostate cancer and understand the long-term benefits of robotic surgery through patient reported questionnaires. Outcomes from this database will also help compare the quality of care against other powerhouses of robotic surgery.
Eventually, the database aims to standardize diagnostic pathways and clinical notes that are the same across different hospitals conducting robotic-assisted surgeries for Prostatectomy and improve care for prostate cancer patients across the country.
Inclusion: To be eligible to participate in this database, an individual must meet all of the following criteria:; Individuals who consent to participate,; within the age range of 18 to 90 years,; confirmed diagnosis of localized prostate cancer (PCa); patients receiving medical attention at hospitals engaged in collaborative efforts with the designated database.
Exclusion: Individuals who have not undergone robotic surgery for prostatectomy or TP biopsy. ,; without a diagnosis of prostate cancer or; Under the age of 18 years; Participants are not eligible to take part in the database:; who decline to provide consent for the collection of their health information.